v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04603690 |
Full text link
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Dec. 12, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Dec. 12, 2020, 12:31 a.m. Source : ClinicalTrials.gov |
ikramujjan@lumhs.edu.pk |
Registration date
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-10-27 |
Recruitment status
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
inclusion criteria: patients must be 18 years of age or older, of either gender patients must be tested positive for sars-cov-2 by rt-pcr within 72 hours prior to enrolment patients must exhibit typical symptoms of covid-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc. patients must be in the early stage of covid-19 disease who do not require hospitalization at the time of screening patients must be under the care of a physician for diagnosis of covid-19 patients who have signed informed consent |
Exclusion criteria
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
patients with proven hypersensitivity or allergic reaction to quercetin or curcumin patients with known chronic kidney disease with estimated creatinine clearance < 50 ml/minute or need for dialysis patients who are severely hypotensive defined as needing hemodynamic pressors to maintain blood pressure patients taking anticoagulant/antiplatelet drugs such as coumarine, heparine, aspirin, clopidrogel, dalteparin, enoxaparin, ticlopidine and warparin. patients with gallstone obstruction hypothyroid suffering patients patients with moderate or severe thrombocytopenia (platelet count <100 ×10⁹/l); pregnant patients |
Number of arms
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Liaquat University of Medical & Health Sciences |
Inclusion age min
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Pakistan |
Type of patients
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
50 |
primary outcome
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
COVID-19 symptoms improvement;SARS-CoV-2 Negativity by RT-PCR |
Notes
Last imported at : Oct. 27, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 1476, "treatment_name": "Curcumin+quercetin+vitamin d3", "treatment_type": "Vitamins and dietary supplements+others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |